HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myung Joo Kang Selected Research

Pep-1 peptide

1/2013Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
12/2010Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Myung Joo Kang Research Topics

Disease

7Neoplasms (Cancer)
11/2020 - 08/2010
4Infections
05/2018 - 01/2014
4Atopic Dermatitis (Atopic Eczema)
01/2011 - 01/2010
3Hepatitis B
09/2018 - 03/2018
2Osteoarthritis
03/2019 - 05/2014
1Asthma (Bronchial Asthma)
07/2021
1Dementia (Dementias)
07/2021
1Rhinitis
07/2021
1Onychomycosis (Tinea Unguium)
03/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2020
1Ovarian Neoplasms (Ovarian Cancer)
06/2020
1Pain (Aches)
03/2019
1Tics (Tic)
02/2017
1Gingivitis
01/2017
1Inflammation (Inflammations)
01/2017
1Breast Neoplasms (Breast Cancer)
10/2016
1Wounds and Injuries (Trauma)
05/2016
1Gastritis
01/2016
1Arthralgia (Joint Pain)
01/2016
1Osteoporosis
09/2014
1Esophagitis
09/2014
1Arthritis (Polyarthritis)
05/2014
1Candidiasis (Moniliasis)
01/2014

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
11/2020 - 01/2013
5Liposomes (Liposome)IBA
05/2017 - 01/2010
4RIPL peptideIBA
06/2020 - 08/2014
4hepsinIBA
06/2020 - 08/2014
3LipidsIBA
06/2020 - 01/2014
3Peptides (Polypeptides)IBA
08/2014 - 01/2011
2HydrogelsIBA
11/2020 - 01/2014
2Hyaluronic Acid (Hyaluronan)IBA
03/2019 - 05/2014
2entecavirFDA Link
05/2018 - 03/2018
2SolutionsIBA
01/2018 - 05/2017
2Piroxicam (Feldene)FDA LinkGeneric
01/2016 - 05/2014
2Pep-1 peptideIBA
01/2013 - 12/2010
2oregoninIBA
08/2010 - 01/2010
1montelukast (Singulair)FDA Link
07/2021
1TriazolesIBA
03/2021
1efinaconazoleIBA
03/2021
1Docetaxel (Taxotere)FDA Link
06/2020
1KetorolacIBA
03/2019
1SuspensionsIBA
09/2018
1Fluorescent Dyes (Fluorescent Probes)IBA
05/2017
1Drug CarriersIBA
02/2017
1OligopeptidesIBA
02/2017
1Artificial SalivaIBA
01/2017
1Polymethyl Methacrylate (Sol)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
1Estrogen ReceptorsIBA
10/2016
1human ERBB2 proteinIBA
10/2016
1Lapatinib (GW572016)FDA Link
10/2016
1Letrozole (Femara)FDA LinkGeneric
10/2016
1ChitosanIBA
05/2016
1Anti-Infective Agents (Microbicides)IBA
05/2016
1PolymersIBA
05/2016
1jaceosidinIBA
01/2016
1eupatilinIBA
01/2016
1DA 9601IBA
01/2016
1Dosage Forms (Dosage Form)IBA
01/2016
1Risedronic Acid (Actonel)FDA LinkGeneric
09/2014
1AcidsIBA
09/2014
1Diphosphonates (Bisphosphonates)IBA
09/2014
1Analgesics (Analgesic Drugs)IBA
05/2014
1Voriconazole (Vfend)FDA LinkGeneric
01/2014
1LigandsIBA
01/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2013
1hirsutenoneIBA
01/2011
1diphenylcyclopropenoneIBA
01/2011
1taxifolinIBA
12/2010
1GlycosidesIBA
12/2010
1CalciumIBA
08/2010
1InterleukinsIBA
08/2010
1Free RadicalsIBA
08/2010
1NitrogenIBA
08/2010
1CytokinesIBA
08/2010
1DiarylheptanoidsIBA
08/2010

Therapy/Procedure

1Intravesical Administration
11/2020
1Injections
01/2018
1Neoadjuvant Therapy
10/2016
1Therapeutics
01/2014
1Intraperitoneal Injections
08/2010